11 hours ago
New weight loss pill set to rival 'fat jab' shows promising results in early trials
A new weight loss treatment that can be taken as either a daily pill or a weekly injection has shown very promising results in initial trials, according to a new study.
In one of the tests, 125 adults were assigned weekly injections of a drug called 'AMYCRETIN', and early results showed that those receiving the 60 milligram dose lost nearly a quarter of their body weight over 36 weeks.
'Amycretin' is a 'unimolecular long-acting GLP-1 and amylin receptor agonist' under development by Novo Nordisk, to provide a treatment for adults with obesity and as a treatment for adults with type 2 diabetes. Pic: Shutterstock
If the initial results turn out to be effective in the long run, this may make 'Amycretin' a more effective treatment for obesity than other weight loss drugs like Weygovy and Ozempic.
Another trial enrolled 144 adults to test the 'pill version' of 'Amycretin'. Those who took the 100 milligram daily tablet lost an average of 13.1 percent of their weight over 12 weeks.
Novo-Nordisk, who are heading up the research into this new medication says initial trials suggest Amycretin could be on the market by next year. Pic: Getty Images
The strongest prescription weight loss medication currently approved by the FDA is Semaglutide, marketed under brand names like Wegovy and Ozempic (for diabetes, also used off-label for weight loss).
